Jun 06, 2019 - Celgene (CELG) along with partner Acceleron submits application for luspatercept to the FDA.
Jun 05, 2019 - Celgene (CELG) presents data on myelofibrosis candidate from a phase II study and an oncology candidate at ASCO.
May 09, 2019 - XLRN earnings call for the period ending March 31, 2019.
May 09, 2019 - Call Start: 17:00 Call End: 17:35 Acceleron Pharma, Inc. (NASDAQ:XLRN) Q1 2019 Earnings Conference Call May 9, 2019, 5:00 pm ET Company Participants Todd James - VP, IR & Corporate Communications
May 08, 2019 - Five drug/biotech stocks are scheduled to release their first-quarter results on May 9. Let's take a look at how these companies are poised ahead of their earnings release.
May 08, 2019 - First-quarter 2019 earnings results so far are better than expected.
May 07, 2019 - Within the Life Sciences segment, high investment in several geographies along with product launches and new technologies is resulting in a strong upside for Bio-Rad (BIO).
Apr 26, 2019 - Celgene (CELG) beats on earnings and sales in the first quarter of 2019.
Apr 08, 2019 - Celgene (CELG) and partner Acceleron submit BLA for pipeline candidate, luspatercept to the FDA.
Feb 28, 2019 - SQ earnings call for the period ending December 31, 2018